Mind Medicine (MindMed) Ownership 2024 | Who Owns Mind Medicine (MindMed) Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

0.00%

Insider Ownership

1.04%

Institutional Holders

1.00

Mind Medicine (MindMed) Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
HUNTINGTON NATIONAL BANK--1--1Jun 30, 2024

Mind Medicine (MindMed)'s largest institutional shareholder is HUNTINGTON NATIONAL BANK, holding 0.00% of the company's total share outstanding, currently valued at $1.00. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
HUNTINGTON NATIONAL BANK--1--1Jun 30, 2024

The largest Mind Medicine (MindMed) shareholder by % of total assets is HUNTINGTON NATIONAL BANK. The company owns 1.00 shares of Mind Medicine (MindMed) (MNMD), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
HUNTINGTON NATIONAL BANK--1--1Jun 30, 2024

As of Jun 30 2024, Mind Medicine (MindMed)'s largest institutional buyer is HUNTINGTON NATIONAL BANK. The company purchased 0.00 stocks of MNMD, valued at $1.00.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
HUNTINGTON NATIONAL BANK--1--1Jun 30, 2024

As of Jun 30 2024, Mind Medicine (MindMed)'s biggest institutional seller is HUNTINGTON NATIONAL BANK. The company sold 0.00 shares of MNMD, valued at $1.00.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Mind Medicine (MindMed) Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
AdvisorShares Trust0.19%750,151--Mar 28, 2024
QUANTITATIVE MASTER SERIES LLC0.09%548,974--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.09%51,517--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.04%9,611--Mar 31, 2024
AdvisorShares Trust0.03%109,507-3,267-2.90%Mar 28, 2024
ETF Series Solutions0.02%441,865--Jan 31, 2024
SCHWAB CAPITAL TRUST0.02%718,559--Feb 29, 2024
DRIEHAUS MUTUAL FUNDS0.01%130,522130,522-Mar 28, 2024
Calvert Variable Products, Inc.0.01%25,253--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%134,563--Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%12,332--Mar 31, 2024
Global X Funds0.00%91,385--Jan 31, 2024
TIAA-CREF LIFE FUNDS0.00%5,436--Mar 31, 2024
GPS Funds I0.00%10,334--Mar 31, 2024
Northern Lights Fund Trust IV0.00%500,000--Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%97,100--Mar 31, 2024
Managed Portfolio Series0.00%29,459--Jan 31, 2024
NORTHERN FUNDS0.00%173,646--Mar 28, 2024
FIDELITY CONCORD STREET TRUST0.00%201,145--Feb 29, 2024
EQ ADVISORS TRUST0.00%951,271--Mar 31, 2024
RYDEX SERIES FUNDS0.00%3,202--Dec 31, 2023
ETF Series Solutions0.00%14,955--Jan 31, 2024
iSHARES TRUST0.00%11,427,481--Mar 31, 2024
FIDELITY SALEM STREET TRUST0.00%2,538,429--Mar 31, 2024
Federated Hermes Global Allocation Fund0.00%6,094--Feb 29, 2024
ProFunds0.00%6,888--Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%1,114,059--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%12,460--Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%1,955--Dec 31, 2023
SCHWAB CAPITAL TRUST0.00%18,372--Jan 31, 2024
Goldman Sachs ETF Trust0.00%43,310--Feb 29, 2024
Meeder Funds0.00%2,107--Mar 31, 2024
VALIC Co I0.00%119,377--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%420,716--Mar 31, 2024
PENN SERIES FUNDS INC0.00%10,800--Mar 28, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%47,931--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%45,923--Jan 31, 2024
Guggenheim Active Allocation Fund0.00%1,888--Feb 29, 2024
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%65,117--Feb 29, 2024
RYDEX VARIABLE TRUST0.00%334--Dec 31, 2023
Ultimus Managers Trust0.00%2,882--Feb 29, 2024
TIAA-CREF FUNDS0.00%724,170--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%24,28424,07511519.14%Jan 31, 2024
PROSHARES TRUST0.00%46,420--Feb 29, 2024
MASTER INVESTMENT PORTFOLIO0.00%15,081--Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%12,062--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%293,900--Mar 31, 2024
AMERICAN CENTURY ETF TRUST0.00%11,940--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%35,515--Mar 31, 2024
Brighthouse Funds Trust II0.00%73,240--Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%77,675--Mar 31, 2024
PACIFIC SELECT FUND0.00%122,347--Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%28,047--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%26,185--Dec 31, 2023
BLACKROCK FUNDS0.00%135,545--Mar 28, 2024
USAA MUTUAL FUNDS TRUST0.00%4,015--Jan 31, 2024
SPDR INDEX SHARES FUNDS0.00%2,041--Mar 31, 2024
Bridge Builder Trust0.00%43,020--Mar 31, 2024
BlackRock Variable Series Funds, Inc.0.00%43,122--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%48,906--Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%77,200--Feb 29, 2024
John Hancock Funds II0.00%37,010--Feb 29, 2024
BLACKROCK FUNDS0.00%2,537--Mar 28, 2024

Mind Medicine (MindMed)'s largest mutual fund holder by % of total assets is "AdvisorShares Trust", owning 750.15K shares, compromising 0.19% of its total assets.

Mind Medicine (MindMed) Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 241-
31 Mar, 241-
31 Dec, 231-
30 Sep, 231-
30 Jun, 231-
31 Mar, 231-50.00%
31 Dec, 222-71.43%
30 Sep, 227-94.81%
30 Jun, 22135-11.76%
31 Mar, 22153-8.38%
31 Dec, 21167-6.70%
30 Sep, 2117911.18%
30 Jun, 211611912.50%
31 Mar, 21860.00%
31 Dec, 20566.67%
30 Sep, 203-
30 Jun, 203200.00%
31 Mar, 201-
31 Dec, 191-
30 Sep, 191-
30 Jun, 191-
31 Mar, 191-

As of 30 Jun 24, 1 institutions are holding Mind Medicine (MindMed)'s shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 241-
31 Mar, 241-
31 Dec, 231-
30 Sep, 231-
30 Jun, 231-
31 Mar, 231-100.00%
31 Dec, 22100,351-95.28%
30 Sep, 222,127,840-90.66%
30 Jun, 2222,790,319-52.70%
31 Mar, 2248,185,677-6.63%
31 Dec, 2151,605,50516.30%
30 Sep, 2144,371,23518.20%
30 Jun, 2137,539,26112660.08%
31 Mar, 21294,19345.04%
31 Dec, 20202,842133.69%
30 Sep, 2086,800-51.62%
30 Jun, 20179,400758.37%
31 Mar, 2020,900-
31 Dec, 1920,900-
30 Sep, 1920,900-
30 Jun, 1920,900-
31 Mar, 1920,900-

Mind Medicine (MindMed) (MNMD) has 1.00 shares outstanding as of 30 Jun 24, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 24--
31 Mar, 24--
31 Dec, 23--
30 Sep, 23--
30 Jun, 23--
31 Mar, 23--
31 Dec, 220.33%0.62%
30 Sep, 227.26%25.10%
30 Jun, 225.38%4.13%
31 Mar, 2211.41%7.23%
31 Dec, 2112.57%11.26%
30 Sep, 2110.56%12.34%
30 Jun, 219.25%719.36%
31 Mar, 211.13%185.47%
31 Dec, 200.78%364.30%
30 Sep, 200.46%44.48%
30 Jun, 201.02%4232.00%
31 Mar, 200.16%643.92%
31 Dec, 190.16%1307.06%
30 Sep, 190.11%917.43%
30 Jun, 190.11%917.43%
31 Mar, 190.11%-

As of 30 Jun 24, Mind Medicine (MindMed) is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 24--
31 Mar, 24--
31 Dec, 23--
30 Sep, 23--
30 Jun, 23--
31 Mar, 23--100.00%
31 Dec, 221-
30 Sep, 221-98.44%
30 Jun, 22641.59%
31 Mar, 2263-25.88%
31 Dec, 2185-10.53%
30 Sep, 2195-33.57%
30 Jun, 211432760.00%
31 Mar, 21566.67%
31 Dec, 203200.00%
30 Sep, 201-50.00%
30 Jun, 202-
31 Mar, 20--
31 Dec, 19--
30 Sep, 19--
30 Jun, 19--100.00%
31 Mar, 191-

- institutional shareholders have increased their position in MNMD stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 24--
31 Mar, 24--
31 Dec, 23--
30 Sep, 23--
30 Jun, 23--
31 Mar, 23--100.00%
31 Dec, 221-75.00%
30 Sep, 224-88.89%
30 Jun, 2236-12.20%
31 Mar, 224124.24%
31 Dec, 21333.13%
30 Sep, 2132-
30 Jun, 21--100.00%
31 Mar, 211-
31 Dec, 20--
30 Sep, 20--
30 Jun, 20--
31 Mar, 20--
31 Dec, 19--
30 Sep, 19--
30 Jun, 19--
31 Mar, 19--

- institutional shareholders have reduced their position in MNMD stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 241-1-------
31 Mar, 241-1-------
31 Dec, 231-1-------
30 Sep, 231-1-------
30 Jun, 231-1-------
31 Mar, 231-50.00%1-100.00%----100.00%--100.00%
31 Dec, 222-71.43%100,351-95.28%0.33%0.62%1-1-75.00%
30 Sep, 227-94.81%2,127,840-90.66%7.26%25.10%1-98.44%4-88.89%
30 Jun, 22135-11.76%22,790,319-52.70%5.38%4.13%641.59%36-12.20%
31 Mar, 22153-8.38%48,185,677-6.63%11.41%7.23%63-25.88%4124.24%
31 Dec, 21167-6.70%51,605,50516.30%12.57%11.26%85-10.53%333.13%
30 Sep, 2117911.18%44,371,23518.20%10.56%12.34%95-33.57%32-
30 Jun, 211611912.50%37,539,26112660.08%9.25%719.36%1432760.00%--100.00%
31 Mar, 21860.00%294,19345.04%1.13%185.47%566.67%1-
31 Dec, 20566.67%202,842133.69%0.78%364.30%3200.00%--
30 Sep, 203-86,800-51.62%0.46%44.48%1-50.00%--
30 Jun, 203200.00%179,400758.37%1.02%4232.00%2---
31 Mar, 201-20,900-0.16%643.92%----
31 Dec, 191-20,900-0.16%1307.06%----
30 Sep, 191-20,900-0.11%917.43%----
30 Jun, 191-20,900-0.11%917.43%--100.00%--
31 Mar, 191-20,900-0.11%-1---

Mind Medicine (MindMed) Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 25, 2024Karlin Danofficer Chief Medical OfficerS-SaleSell6,925$7.22$50.00K351,527
Jun 25, 2024Barrow Robertdirector, officer Chief Executive OfficerS-SaleSell15,659$7.22$113.06K564,543
Jun 25, 2024Sullivan Markofficer Chief Legal OfficerS-SaleSell17,854$7.22$128.91K182,146
Mar 26, 2024Karlin Danofficer Chief Medical OfficerS-SaleSell6,578$9.50$62.49K358,452
Mar 26, 2024Barrow Robertdirector, officer Chief Executive OfficerS-SaleSell16,519$9.50$156.93K580,202
Dec 26, 2023Karlin Danofficer Chief Medical OfficerS-SaleSell6,774$3.63$24.59K365,030
Dec 26, 2023Barrow Robertdirector, officer Chief Executive OfficerS-SaleSell13,237$3.63$48.05K596,721
Dec 26, 2023Greenway Schond L.officer Chief Financial OfficerS-SaleSell5,652$3.63$20.52K216,617

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 25, 2024Karlin Danofficer Chief Medical OfficerS-SaleSell6,925$7.22$50.00K351,527
Jun 25, 2024Barrow Robertdirector, officer Chief Executive OfficerS-SaleSell15,659$7.22$113.06K564,543
Jun 25, 2024Sullivan Markofficer Chief Legal OfficerS-SaleSell17,854$7.22$128.91K182,146
Mar 26, 2024Greenway Schond L.officer Chief Financial OfficerF-InKindSell5,560$9.78$54.38K211,057
Mar 26, 2024Karlin Danofficer Chief Medical OfficerS-SaleSell6,578$9.50$62.49K358,452
Mar 26, 2024Barrow Robertdirector, officer Chief Executive OfficerS-SaleSell16,519$9.50$156.93K580,202
Dec 26, 2023Karlin Danofficer Chief Medical OfficerS-SaleSell6,774$3.63$24.59K365,030
Dec 26, 2023Barrow Robertdirector, officer Chief Executive OfficerS-SaleSell13,237$3.63$48.05K596,721
Dec 26, 2023Greenway Schond L.officer Chief Financial OfficerS-SaleSell5,652$3.63$20.52K216,617

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 25, 2024Karlin Danofficer Chief Medical OfficerS-SaleSell6,925$7.22$50.00K351,527
Jun 25, 2024Barrow Robertdirector, officer Chief Executive OfficerS-SaleSell15,659$7.22$113.06K564,543
Jun 25, 2024Sullivan Markofficer Chief Legal OfficerS-SaleSell17,854$7.22$128.91K182,146
Jun 12, 2024Vallone Carol Adirector-A-AwardBuy16,506$7.25$119.67K16,506
Jun 12, 2024GRYSKA DAVID Wdirector-A-AwardBuy16,506$7.25$119.67K16,506
Jun 12, 2024CRYSTAL ROGERdirector-A-AwardBuy16,506$7.25$119.67K16,506
Jun 12, 2024Bruhn Suzanne Louisedirector-A-AwardBuy16,506$7.25$119.67K16,506
Jun 12, 2024Krebs Andreasdirector-A-AwardBuy16,506$7.25$119.67K16,506
Mar 26, 2024Greenway Schond L.officer Chief Financial OfficerF-InKindSell5,560$9.78$54.38K211,057
Mar 26, 2024Karlin Danofficer Chief Medical OfficerS-SaleSell6,578$9.50$62.49K358,452
Mar 26, 2024Barrow Robertdirector, officer Chief Executive OfficerS-SaleSell16,519$9.50$156.93K580,202
Feb 29, 2024Wernli Miri Halperinofficer Executive PresidentA-AwardBuy125,000$4.98$622.50K125,000
Feb 29, 2024Greenway Schond L.officer Chief Financial OfficerA-AwardBuy150,000$4.98$747.00K150,000
Feb 29, 2024Sullivan Markofficer Chief Legal OfficerA-AwardBuy125,000$4.98$622.50K125,000
Feb 29, 2024Karlin Danofficer Chief Medical OfficerA-AwardBuy150,000$4.98$747.00K150,000
Feb 29, 2024Liao Carrieofficer Chief Accounting OfficerA-AwardBuy100,000$4.98$498.00K100,000
Feb 29, 2024Barrow Robertdirector, officer Chief Executive OfficerA-AwardBuy400,000$4.98$1.99M400,000
Dec 26, 2023Karlin Danofficer Chief Medical OfficerS-SaleSell6,774$3.63$24.59K365,030
Dec 26, 2023Barrow Robertdirector, officer Chief Executive OfficerS-SaleSell13,237$3.63$48.05K596,721
Dec 26, 2023Greenway Schond L.officer Chief Financial OfficerS-SaleSell5,652$3.63$20.52K216,617

The last insider sell of Mind Medicine (MindMed)'s stock was made by Karlin Dan on Jun 25 2024, selling 6,925 shares at $7.22 per share (valued at $50.00K).

Mind Medicine (MindMed) Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202453166.67%
Q1 202463200.00%
Q4 2023-3-
Q3 2023-7-
Q2 2023126200.00%
Q1 202382400.00%
Q4 2022-6-
Q3 202271070.00%
Q2 20222010200.00%
Q1 202292733.33%

5 total buy trades, and 3 total sell trades (buy/sell ratio of 1.67%) were made by Mind Medicine (MindMed)'s insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-3-
Q1 2024-2-
Q4 2023-3-
Q3 2023-7-
Q2 2023-6-
Q1 2023-2-
Q4 2022-6-
Q3 2022-10-
Q2 2022-7-
Q1 2022---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of Mind Medicine (MindMed)'s stocks.

Mind Medicine (MindMed) Peer Ownership


TickerCompany
CKPTCheckpoint Therapeutics, Inc.
ATAIAtai Life Sciences N.V.
RVPHReviva Pharmaceuticals Holdings, Inc.
EWTXEdgewise Therapeutics, Inc.
GHRSGH Research PLC
BPTHBio-Path Holdings, Inc.
SEELSeelos Therapeutics, Inc.
VCNXVaccinex, Inc.
KODKodiak Sciences Inc.
ITOSiTeos Therapeutics, Inc.
MBIOMustang Bio, Inc.
MOLNMolecular Partners AG
OPTOpthea Limited
ELYMEliem Therapeutics, Inc.

MNMD Ownership FAQ


Mind Medicine (MindMed) is owned by institutional shareholders (0%), insiders (1.04%), and public (0%). The largest institutional shareholder of Mind Medicine (MindMed) is HUNTINGTON NATIONAL BANK (0% of total shares) and the top mutual fund owner is AdvisorShares Trust (0.19% of total shares).

Mind Medicine (MindMed)'s major institutional shareholders are HUNTINGTON NATIONAL BANK. The top five shareholders own together 0% of the company's share outstanding.

As of Jun 2024, there are 1 institutional shareholders of Mind Medicine (MindMed).

HUNTINGTON NATIONAL BANK owns 1 shares of Mind Medicine (MindMed), representing 0% of the company's total shares outstanding, valued at $1 (as of Jun 2024).